Literature DB >> 26048995

Response.

Kimmie Ng1, Andrew T Chan2, Charles S Fuchs2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26048995      PMCID： PMC4609555          DOI： 10.1093/jnci/djv150

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  A randomized trial of aspirin to prevent colorectal adenomas.

Authors:  John A Baron; Bernard F Cole; Robert S Sandler; Robert W Haile; Dennis Ahnen; Robert Bresalier; Gail McKeown-Eyssen; Robert W Summers; Richard Rothstein; Carol A Burke; Dale C Snover; Timothy R Church; John I Allen; Michael Beach; Gerald J Beck; John H Bond; Tim Byers; E Robert Greenberg; Jack S Mandel; Norman Marcon; Leila A Mott; Loretta Pearson; Fred Saibil; Rosalind U van Stolk
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

2.  A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

Authors:  Robert S Sandler; Susan Halabi; John A Baron; Susan Budinger; Electra Paskett; Roger Keresztes; Nicholas Petrelli; J Marc Pipas; Daniel D Karp; Charles L Loprinzi; Gideon Steinbach; Richard Schilsky
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

3.  Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.

Authors:  Rachel S Midgley; Christopher C McConkey; Elaine C Johnstone; Janet A Dunn; Justine L Smith; Simon A Grumett; Patrick Julier; Claire Iveson; Yoko Yanagisawa; Bryan Warren; Michael J Langman; David J Kerr
Journal:  J Clin Oncol       Date:  2010-09-13       Impact factor: 44.544

4.  Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.

Authors:  Robert Benamouzig; Jacques Deyra; Antoine Martin; Bernard Girard; Eric Jullian; Benoit Piednoir; Daniel Couturier; Thierry Coste; Julian Little; Stanislas Chaussade
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

5.  Aspirin use and survival after diagnosis of colorectal cancer.

Authors:  Andrew T Chan; Shuji Ogino; Charles S Fuchs
Journal:  JAMA       Date:  2009-08-12       Impact factor: 56.272
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.